Proteomic Analysis of Saliva from Patients with Oral Chronic Graft-Versus-Host Disease

Lee, 2003, Chronic graft-versus-host disease, Biol Blood Marrow Transplant, 9, 215, 10.1053/bbmt.2003.50026 Lee, 2008, Recognizing and managing chronic graft-versus-host disease, Hematology Am Soc Hematol Educ Program, 134, 10.1182/asheducation-2008.1.134 Filipovich, 2005, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, I: Diagnosis and Staging Working Group report, Biol Blood Marrow Transplant, 11, 945, 10.1016/j.bbmt.2005.09.004 Shlomchik, 2007, Graft-versus-host disease, Nat Rev Immunol, 7, 340, 10.1038/nri2000 Shimabukuro-Vornhagen, 2009, The role of B cells in the pathogenesis of graft-versus-host disease, Blood, 114, 4919, 10.1182/blood-2008-10-161638 Schubert, 1984, Oral manifestations of chronic graft-v-host disease, Arch Intern Med, 144, 1591, 10.1001/archinte.1984.00350200087014 Fall-Dickson, 2010, Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease, Biol Blood Marrow Transplant, 16, 948, 10.1016/j.bbmt.2010.01.017 Nagler, 2004, The molecular basis of salivary gland involvement in graft-vs.-host disease, J Dent Res, 83, 98, 10.1177/154405910408300203 Pimentel, 2010, Perforin and granzyme B involvement in oral lesions of lichen planus and chronic GVHD, J Oral Pathol Med, 39, 741, 10.1111/j.1600-0714.2010.00917.x Al-Tarawneh, 2011, Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review, OMICS, 15, 353, 10.1089/omi.2010.0134 Loo, 2010, Comparative human salivary and plasma proteomes, J Dent Res, 89, 1016, 10.1177/0022034510380414 Imanguli, 2007, Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation, Exp Hematol, 35, 184, 10.1016/j.exphem.2006.10.009 Bassim, 2012, Quantitative salivary proteomic differences in oral chronic graft-versus-host disease, J Clin Immunol, 32, 1390, 10.1007/s10875-012-9738-4 Hegenbart, 2006, Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors, J Clin Oncol, 24, 444, 10.1200/JCO.2005.03.1765 Arai, 2011, Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria, Blood, 118, 4242, 10.1182/blood-2011-03-344390 Devic, 2011, Salivary alpha-synuclein and DJ-1: potential biomarkers for Parkinson's disease, Brain, 134, e178, 10.1093/brain/awr015 Abdi, 2006, Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders, J Alzheimers Dis, 9, 293, 10.3233/JAD-2006-9309 Ramachandran, 2006, Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry, J Proteome Res, 5, 1493, 10.1021/pr050492k Shilov, 2007, The Paragon Algorithm, a next-generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra, Mol Cell Proteomics, 6, 1638, 10.1074/mcp.T600050-MCP200 Drummelsmith, 2007, Comparative proteomics analyses reveal a potential biomarker for the detection of vancomycin-intermediate Staphylococcus aureus strains, J Proteome Res, 6, 4690, 10.1021/pr070521m Huang da, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat Protoc, 4, 44, 10.1038/nprot.2008.211 Seggewiss, 2010, Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update, Blood, 115, 3861, 10.1182/blood-2009-12-234096 Serody, 2012, The IL-17 differentiation pathway and its role in transplant outcome, Biol Blood Marrow Transplant, 18, S56, 10.1016/j.bbmt.2011.10.001 Gallo, 2012, Epithelial antimicrobial defence of the skin and intestine, Nat Rev Immunol, 12, 503, 10.1038/nri3228 Fujii, 2008, Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group, Blood, 111, 3276, 10.1182/blood-2007-08-106286 Shulman, 2006, Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease, II: Pathology Working Group Report, Biol Blood Marrow Transplant, 12, 31, 10.1016/j.bbmt.2005.10.023 Nagler, 2004, Salivary gland involvement in graft-versus-host disease: the underlying mechanism and implicated treatment, Isr Med Assoc J, 6, 167 Soares, 2005, Chronic GVHD in minor salivary glands and oral mucosa: histopathological and immunohistochemical evaluation of 25 patients, J Oral Pathol Med, 34, 368, 10.1111/j.1600-0714.2005.00322.x Noce, 2012, Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients, Gen Dent, 59, 458 Norhagen, 1994, Salivary and serum immunoglobulins in recipients of transplanted allogeneic and autologous bone marrow, Bone Marrow Transplant, 14, 229 Nagler, 2001, The effect of pilocarpine on salivary constituents in patients with chronic graft-versus-host disease, Arch Oral Biol, 46, 689, 10.1016/S0003-9969(01)00035-8 Arend, 1998, Interleukin-1 receptor antagonist: role in biology, Annu Rev Immunol, 16, 27, 10.1146/annurev.immunol.16.1.27 Cullup, 2001, Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen–matched sibling allogeneic transplants, Br J Haematol, 113, 807, 10.1046/j.1365-2141.2001.02811.x Rocha, 2002, Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation, Blood, 100, 3908, 10.1182/blood-2002-04-1033 Arend, 2002, The balance between IL-1 and IL-1Ra in disease, Cytokine Growth Factor Rev, 13, 323, 10.1016/S1359-6101(02)00020-5 Sun, 2012, Increased expression of stefin B in the nucleus of T98G astrocytoma cells delays caspase activation, Front Mol Neurosci, 5, 93, 10.3389/fnmol.2012.00093 Rivera-Rivera, 2011, Inhibition of interferon response by cystatin B: implication in HIV replication of macrophage reservoirs, J Neurovirol, 18, 20, 10.1007/s13365-011-0061-2 Cabras, 2011, RP-HPLC-ESI-MS evidenced that salivary cystatin B is detectable in adult human whole saliva mostly as S-modified derivatives: S-glutathionyl, S-cysteinyl and S-S 2-mer, J Proteomics, 75, 908, 10.1016/j.jprot.2011.10.006 Levine, 2012, Clinical applications for biomarkers of acute and chronic graft-versus-host disease, Biol Blood Marrow Transplant, 18, S116, 10.1016/j.bbmt.2011.10.019 Boukouaci, 2009, MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease, Blood, 114, 5216, 10.1182/blood-2009-04-217430 Pratt, 2013, IL-15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD, Bone Marrow Transplant, 48, 722, 10.1038/bmt.2012.210 Kitko, 2014, Plasma CXCL9 elevations correlate with chronic GVHD diagnosis, Blood, 123, 786, 10.1182/blood-2013-08-520072 Mays JW, Weller ML, Bassim CW, et al. Oral graft-versus-host disease is distinguished by inflammation and impaired anti-microbial immunity. Presented at the 43rd Annual Meeting of the American Association for Dental Research, 2014. Available from: https://iadr.confex.com/iadr/43am/webprogram/start.html. Accessed March 10, 2014.